We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+14.4%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$2.47B
AUM Growth
-$383M
Cap. Flow
-$659M
Cap. Flow %
-26.68%
Top 10 Hldgs %
20.57%
Holding
503
New
157
Increased
65
Reduced
85
Closed
179

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$69.6M
2
LOW icon
Lowe's Companies
LOW
+$47.6M
3
NSC icon
Norfolk Southern
NSC
+$37.4M
4
HAS icon
Hasbro
HAS
+$36.3M
5
DLTR icon
Dollar Tree
DLTR
+$34.4M

Top Sells

Rank Stock Value
1
SN icon
SharkNinja
SN
+$69.8M
2
MSFT icon
Microsoft
MSFT
+$64.6M
3
DIS icon
Walt Disney
DIS
+$62.7M
4
KVUE icon
Kenvue
KVUE
+$48.3M
5
TGT icon
Target
TGT
+$44.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.49%
2 Technology 10.33%
3 Industrials 10.03%
4 Healthcare 8.86%
5 Communication Services 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCVX icon
226
Vaxcyte
PCVX
$7.73B
$1.11M 0.05%
17,694
+9,010
+104% +$468K
AMLX icon
227
CALL
Amylyx Pharmaceuticals
AMLX
$2.24B
$1.1M 0.04%
75,000
+45,000
+150% +$690K
CTRN icon
228
Citi Trends
CTRN
$582M
$1.08M 0.04%
38,100
-38,357
-50% -$932K
COF icon
229
Capital One
COF
$134B
$1.07M 0.04%
+8,129
New +$877K
AUPH icon
230
Aurinia Pharmaceuticals
AUPH
$1.87B
$1.02M 0.04%
113,550
-273,003
-71% -$2.25M
VET icon
231
Vermilion Energy
VET
$1.76B
$963K 0.04%
+79,832
New +$1.06M
AVDL
232
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
$953K 0.04%
+67,500
New +$793K
VSXY
233
PUT
Victoria's Secret
VSXY
$7.08B
$929K 0.04%
+35,000
New +$742K
IMCR icon
234
PUT
Immunocore
IMCR
$1.65B
$922K 0.04%
+13,500
New +$702K
PENN icon
235
PENN Entertainment
PENN
$2.67B
$911K 0.04%
35,000
-433,369
-93% -$10.1M
MLCO icon
236
PUT
Melco Resorts & Entertainment
MLCO
$2.17B
$906K 0.04%
+102,100
New +$832K
RVLV icon
237
PUT
Revolve Group
RVLV
$1.86B
$870K 0.04%
+52,500
New +$775K
CLNE icon
238
CALL
Clean Energy Fuels
CLNE
$410M
$868K 0.04%
+226,700
New +$826K
AMGN icon
239
PUT
Amgen
AMGN
$204B
$864K 0.04%
3,000
-37,000
-93% -$10.1M
FXI icon
240
PUT
iShares China Large-Cap ETF
FXI
$4.35B
$817K 0.03%
34,000
+6,300
+23% +$160K
RCKT icon
241
PUT
Rocket Pharmaceuticals
RCKT
$372M
$809K 0.03%
+27,000
New +$596K
INSM icon
242
Insmed
INSM
$21.3B
$806K 0.03%
26,014
-647
-2% -$16.8K
BP icon
243
BP
BP
$114B
$797K 0.03%
+22,500
New +$824K
VRCA icon
244
Verrica Pharmaceuticals
VRCA
$90.2M
$791K 0.03%
+10,800
New +$444K
IMTXW
245
CALL
DELISTED
Immatics N.V. Warrants
IMTXW
$788K 0.03%
94,484
+67,500
+250% +$172K
STNG icon
246
Scorpio Tankers
STNG
$3.89B
$761K 0.03%
12,518
-10,847
-46% -$611K
WWW icon
247
Wolverine World Wide
WWW
$1.62B
$760K 0.03%
+85,480
New +$727K
SHCR
248
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$746K 0.03%
690,879
+240,021
+53% +$246K
NATH icon
249
Nathan's Famous
NATH
$403M
$730K 0.03%
+9,360
New +$641K
OLMA icon
250
Olema Pharmaceuticals
OLMA
$985M
$712K 0.03%
50,766
+19,434
+62% +$261K

Similar funds

J. Goldman & Co's Q4 2023 Portfolio in Review

As of Q4 2023, J. Goldman & Co held 503 positions worth $2.47B, down 13% from $2.85B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

J. Goldman & Co withdrew a net $659M in Q4 2023, closing 179 positions and reducing 85 holdings. Its most notable exit was Kenvue, an estimated $48.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

Against the trend, J. Goldman & Co opened a new position in Lowe's Companies worth $52.2M.

  • J. Goldman & Co's largest Q4 2023 buy was Lowe's Companies: 234,677 shares worth $52.2M.
  • J. Goldman & Co added most to PayPal in Q4 2023, an estimated $69.6M increase.
  • J. Goldman & Co's biggest Q4 2023 reduction was SharkNinja, cutting an estimated $69.8M.
  • J. Goldman & Co fully exited Kenvue in Q4 2023, selling an estimated $48.3M.
  • J. Goldman & Co's ten largest holdings make up 21% of its $2.47B portfolio in Q4 2023.
  • J. Goldman & Co opened 157 new positions and closed 179 in Q4 2023.
  • J. Goldman & Co's portfolio value fell 13% quarter-over-quarter to $2.47B.

Based on J. Goldman & Co's 13F filing for Q4 2023, filed 14 Feb 2024.